Odds of Severe COVID-19 High for Hematologic Cancer Patients During Pandemic
THURSDAY, Feb. 29, 2024 -- For patients with hematologic cancers, the odds of developing severe COVID-19 despite vaccination remained high through mid-2022, according to a study published online Feb. 23 in JAMA Network Open.
Sonia T. Anand, Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 29, 2024 Category: Pharmaceuticals Source Type: news
Cancer Prevention Strategies Linked to Mortality Reduction in BRCA Carriers
(MedPage Today) -- Risk management strategies including bilateral salpingo-oophorectomy (BSO) for ovarian cancer and MRI surveillance for breast cancer were associated with a significant reduction in mortality for women with BRCA1/2 sequence variations... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 29, 2024 Category: Hematology Source Type: news
' There's Nothing Left to Try:' Oncologists on Managing Grief'There's Nothing Left to Try:' Oncologists on Managing Grief
Five oncologists explored the challenges of caring for patients with cancer and how they deal with their complex feelings when a patient dies.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 29, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
' There's Nothing Left to Try': Oncologists on Managing Grief'There's Nothing Left to Try': Oncologists on Managing Grief
Five oncologists explored the challenges of caring for patients with cancer and how they deal with their complex feelings when a patient dies.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - February 29, 2024 Category: Psychiatry Tags: Hematology-Oncology Source Type: news
Low-Dose Aspirin Associated With Reduced CRC Risk Low-Dose Aspirin Associated With Reduced CRC Risk
A Norwegian nationwide study revealed that the impact of low-dose aspirin use was greatest for metastatic colorectal cancer and increased with a longer duration of use.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
Tumor Microbiome Differs in Young- vs Average-Onset CRC Tumor Microbiome Differs in Young- vs Average-Onset CRC
Specific microbes may distinguish the pathogenesis of young-onset colorectal cancer and serve as preventive, diagnostic, and therapeutic targets.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
Digital Support Offers Relief for Cancer Caregivers' Stress Digital Support Offers Relief for Cancer Caregivers' Stress
A customized psychoeducational intervention delivered through a mobile app to caregivers can reduce their anxiety and depression levels.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
GSK Settles Another Lawsuit on Heartburn Drug Zantac in California GSK Settles Another Lawsuit on Heartburn Drug Zantac in California
GSK agreed to confidentially settle another lawsuit in California that had alleged its discontinued heartburn drug Zantac caused cancer, the latest in a series of...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 29, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news
AML: Genetic Testing Unlocks Hope AML: Genetic Testing Unlocks Hope
AML is a deadly form of blood cancer, but advancements in treatment options have improved survival rates, particularly for children.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 29, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
UK Trails Other Nations in Cancer Treatment and Wait Times UK Trails Other Nations in Cancer Treatment and Wait Times
The NHS must prioritise the cancer treatment backlog to prevent more lives being lost, an oncologist says.Medscape News UK (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 28, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
New Trials in Leukemia/Lymphoma: Could Your Patient Benefit? New Trials in Leukemia/Lymphoma: Could Your Patient Benefit?
Perhaps one of your patients would benefit from enrolling in a new clinical trial in leukemia or lymphoma?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 28, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
FDA Warns Of Potential Risk From Hologic's Devices Implanted in Soft Tissue FDA Warns Of Potential Risk From Hologic's Devices Implanted in Soft Tissue
The U.S. health regulator on Tuesday warned patients and healthcare providers about the potential risk of serious complications arising from the use of Hologic ' s devices...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - February 27, 2024 Category: Cancer & Oncology Tags: Ob/Gyn & Women ' s Health Source Type: news
Regional Nodal Radiation in Early Breast Cancer Regional Nodal Radiation in Early Breast Cancer
Dr Kathy Miller discusses the most recent results on regional nodal radiation from the Early Breast Cancer Trialists ' Collaborative Group.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma Doxorubicin Ups Breast Cancer Risk in Hodgkin Lymphoma
The findings may have implications for breast cancer surveillance among survivors of Hodgkin lymphoma.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 27, 2024 Category: Drugs & Pharmacology Tags: Hematology-Oncology Source Type: news
Disappointing Sotorasib Results: How to Move Forward Disappointing Sotorasib Results: How to Move Forward
Dr Mark Kris discusses the meeting of the Oncologic Drugs Advisory Committee with FDA on October 5, 2023.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
